Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain
Authors:
- Manuel Herrero-MontesMHManuel Herrero-Montes
- César Fernández-De-Las-PeñasCésar Fernández-De-Las-Peñas
- Diego Ferrer-PargadaDFDiego Ferrer-Pargada
- Sheila Izquierdo-CuervoSISheila Izquierdo-Cuervo
- Beatriz Abascal-BoladoBABeatriz Abascal-Bolado
- Juan Antonio Valera-CaleroJVJuan Antonio Valera-Calero
- Paula Paras-BravoPaula Paras-Bravo
Open Access
- 23 February 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (5) , 847
Abstract
Pain symptoms after the acute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are present in almost 50% of COVID-19 survivors. The presence of kinesiophobia is a risk factor which may promote and perpetuate pain. This study aimed to investigate variables associated with the presence of kinesiophobia in a sample of previously hospitalized COVID-19 survivors exhibiting post-COVID pain. An observational study was conducted in three urban hospitals in Spain, including one hundred and forty-six COVID-19 survivors with post-COVID pain. Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety level, depressive level, sleep quality), cognitive (catastrophizing), sensitization-associated symptoms, and health-related quality of life variables were collected in 146 survivors with post-COVID pain, as well as whether they exhibited kinesiophobia. Stepwise multiple linear regression models were conducted to identify variables significantly associated with kinesiophobia. Patients were assessed a mean of 18.8 (SD 1.8) months after hospital discharge. Kinesiophobia levels were positively associated with anxiety levels (r: 0.356, p < 0.001), depression levels (r: 0.306, p < 0.001), sleep quality (r: 0.288, p < 0.001), catastrophism (r: 0.578, p < 0.001), and sensitization-associated symptoms (r: 0.450, p < 0.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r2 adj: 0.329, B = 0.416, t = 8.377, p < 0.001) and sensitization-associated symptoms (r2 adj: 0.381, B = 0.130, t = 3.585, p < 0.001). Kinesiophobia levels were associated with catastrophism and sensitization-associated symptoms in previously hospitalized COVID-19 survivors with post-COVID pain. Identification of patients at a higher risk of developing a higher level of kinesiophobia, associated with post-COVID pain symptoms, could lead to better therapeutic strategies.Keywords
Funding Information
- Comunidad de Madrid y la Unión Europea (0067235)
- Recursos REACT-UE del Programa Operativo de Madrid 2014–2020 (0067235)
- Next-Val 2021 de la Fundación Instituto de Investigación Marqués de Valdecilla (IDIVAL) (0067235)
- Novo Nordisk Foundation (0067235)
This publication has 61 references indexed in Scilit:
- Fear-avoidance model of chronic musculoskeletal pain: 12 years onPain, 2012
- The Development and Psychometric Validation of the Central Sensitization InventoryPain Practice, 2011
- Hospital Anxiety and Depression Scale, Deutsche Version (HADS-D)Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 2011
- Norming of the Tampa Scale for Kinesiophobia across pain diagnoses and various countriesPain, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Pain catastrophizing: a critical reviewExpert Review of Neurotherapeutics, 2009
- Psychological determinants of problematic outcomes following Total Knee ArthroplastyPain, 2009
- What do the numbers mean? Normative data in chronic pain measuresPain, 2008
- Psychometric properties of the TSK-11: A shortened version of the Tampa Scale for KinesiophobiaPain, 2005
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989